↓ Skip to main content

CIP2A is a target of bortezomib in human triple negative breast cancer cells

Overview of attention for article published in Breast Cancer Research, April 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
80 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CIP2A is a target of bortezomib in human triple negative breast cancer cells
Published in
Breast Cancer Research, April 2012
DOI 10.1186/bcr3175
Pubmed ID
Authors

Ling-Ming Tseng, Chun-Yu Liu, Kung-Chi Chang, Pei-Yi Chu, Chung-Wai Shiau, Kuen-Feng Chen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Pakistan 1 1%
Canada 1 1%
Unknown 78 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 25%
Researcher 13 16%
Student > Bachelor 8 10%
Student > Doctoral Student 6 8%
Other 4 5%
Other 14 18%
Unknown 15 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 30%
Biochemistry, Genetics and Molecular Biology 18 23%
Medicine and Dentistry 10 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Chemistry 2 3%
Other 5 6%
Unknown 18 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2023.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from Breast Cancer Research
#977
of 2,052 outputs
Outputs of similar age
#59,269
of 175,641 outputs
Outputs of similar age from Breast Cancer Research
#18
of 38 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,641 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.